Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: CBD

Right On Brands (RTON) to Introduce New CBD Product Endo Water Pure

Los Angeles, CA, Feb. 08, 2018 (GLOBE NEWSWIRE) — Right On Brands, Inc. (OTCQB: RTON) new CBD based Endo Water™ product will soon be available in an unflavored version and will launch as ENDO Water PURE. The new Endo Water™ PURE has Zero calories, sugars, and carbohydrates.

Endo Water™ is a pH balanced water infused with a 99.5% pure CBD oil processed using Nano Technology that makes the particles one-millionth of its normal size. This process allows the Nano-Sized CBD’s to immediately penetrates your cells as opposed to the lengthy process of being absorbed by the body’s digestive system. All CBD offerings will be a part of Endo Brands™ family of products a wholly owned subsidiary of Right On Brands.

“We have had some wins in the first two weeks of sales; retailers have been adding ENDO Water™ products to their inventories and consumers are asking …

Continue Reading

Posted in Client News| Tagged , |

Endo Drops Introduced to CBD Brand Lineup by Right On Brands (RTON)

LOS ANGELES, CA, Jan. 29, 2018 (GLOBE NEWSWIRE) — Right On Brands, Inc. (OTCQB: RTON) has introduced a new product to its CBD based Endo Brands product line Endo Drops.

The Endo Select Hemp oil based Endo Drops are now available in three flavors: Berry, Ginger Citrus, and Spearmint. Purchasing information is available on the corporate website.

Ordering information: or

Tinctures are liquid extracts made from herbs that you take orally by mouth. Cannabinoid Rich Hemp Oil tinctures are the most popular and the most economical way for one to ingest for personal use. The use of cannabis tincture was widespread in the 1800s and appeared in the US pharmacopeia until 1942. The absorption is rapid and begins to occur in the mucous membranes. Tinctures combine hemp oil into a liquid making it easy to consume using a dropper or pump bottle.

Endo Drops are …

Continue Reading

Posted in Client News| Tagged , , |

Medical Marijuana, Inc. Subsidiary HempMeds® Sponsors International Medical Cannabis Expo in Colombia

SAN DIEGO, Nov. 28, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® was a Gold Sponsor of EXPO MEDE Weed, the second International Fair of Medical Cannabis, which took place in Medellín, Colombia on November 24-27, 2017.

This conference is organized annually to discuss the legality of medical cannabis globally. Currently in Colombia, non-psychotropic Cannabis (Hemp) is legal to grow if it contains less than 1% THC.

At the conference, executives from the Medical Marijuana, Inc. portfolio of companies spoke to hundreds of patients and doctors at the event about CBD and shared stories of previous international successes in Mexico, Brazil and Paraguay. Speakers included Dr. Stuart Titus, CEO of Medical Marijuana, Inc., and Raul Elizalde, President of HempMeds® Mexico.

“We are proud to sponsor this global event and speak with an international audience about our products …

Continue Reading

Posted in Client News| Tagged , |

Medical Marijuana, Inc. Subsidiary Kannaway® Announces New Pure Gold Zero-THC Hemp CBD Oil

SAN DIEGO, Nov. 6, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has introduced Kannaway® Pure Gold, a full-spectrum hemp oil that provides all the benefits of hemp without the presence of THC.

Kannaway® Pure Gold is ideal for anyone who is subject to drug tests, including active and retired military, competing athletes, first-responders, or anyone concerned about THC in their daily CBD supplement. Starting with the same high-quality hemp oil used in all Kannaway products, new Kannaway® Pure Gold Liquid has been filtered down to include non-existent levels of THC to create the highest quality possible cannabinoid-dense CBD oil product.  

“We are very glad to be able to expand our customer base by offering the Kannaway® Pure Gold high-quality CBD oil to those who want to incorporate CBD into their lives without the presence of …

Continue Reading

Posted in Client News| Tagged , |
HempMeds® Brazil

HempMeds Brazil Scores Key Legal Victory and Gains Notoriety

HempMeds® Brazil

Medical Marijuana Inc. (OTC MJNA) has received recognition over the past year for its innovative products and successful marketing, which have made it a forerunner in the field of medicinal marijuana. The company and its subsidiary, Kannaway, accomplished record sales over the course of the past year. Now, another of Medical Marijuana Inc.’s subsidiaries, HempMeds®, is proving itself as a revolutionary as well, reforming the traditional views on marijuana in Brazil.

Who is HempMeds® Brazil?

HempMeds® is a subsidiary of Medical Marijuana Inc., which is a company that focuses on cannabis and hemp products. HempMeds® Brazil is the first company to gain legal approval to ship cannabis-related products into Brazil. All three products currently manufactured by HempMeds® Brazil are subsidized under Brazil’s health care system through the government. Their products are designed to treat conditions like epilepsy and Parkinson’s as well as chronic pain. As of now, the company …

Continue Reading

Posted in Articles| Tagged , , , , |

Medical Marijuana, Inc. Announces Prominent Coverage on Mexican News Station About Benefits of CBD and Global CBD Policy

SAN DIEGO, Nov. 2, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, General Manager of subsidiary HempMeds® Mexico, was recently interviewed on Azteca TV Mexico, resulting in notable media coverage of his upcoming speaking engagement at the World Health Organization Drug Scheduling Convention on Psychotropic Substances on November 6, 2017.

According to the interview, Elizalde explained that “The World Health Organization will address cannabidiol along with a list of other substances that they are analyzing to know if they need to be updated and scheduled as psychoactive substances. Cannabidiol is not psychoactive and we wonder how cannabidiol ended up in a list of substances with some synthetic ones like ketamine and vigabatrin.” He later went on to say that “part of what I’m going to do at the World Health Organization is to talk to …

Continue Reading

Posted in Client News| Tagged , |